(Q35685969)

9 August 2017

1 reference

title

Immunoglobulin therapy: history, indications, and routes of administration (English)

1 reference

9 August 2017

Catherine R Weiler

1

1 reference

9 August 2017

language of work or name

1 reference

1 March 2004

1 reference

International Journal of Dermatology

9 August 2017

published in

1 reference

9 August 2017

volume

43

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

163-166

1 reference

Intravenous immunoglobulins: clinical experience and viral safety

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Intravenous immunoglobulin consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Antibody-directed therapy: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Immunoglobulin replacement therapy by slow subcutaneous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2004.02236.X

10.1111/J.1365-4632.2004.02236.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference